Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 850 | 2,270 | 2,674 | 782 | 1,390 |
| Marketable Securities | 2,489 | 2,985 | 2,240 | 4,178 | 3,220 |
| Receivables | 1,005 | 631 | 611 | 384 | 490 |
| Inventories | 946 | 1,207 | 1,649 | 1,667 | 1,600 |
| Income taxes - deferred | 31 | 15 | 31 | 59 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 260 |
| TOTAL | $5,469 | $7,268 | $7,363 | $7,151 | $6,960 |
| Non-Current Assets | |||||
| PPE Net | 3,838 | 2,525 | 2,358 | 2,515 | 2,710 |
| Investments And Advances | 496 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,249 | 1,168 | 1,310 | 1,325 | 1,070 |
| TOTAL | $5,583 | $3,693 | $3,667 | $3,841 | $3,780 |
| Total Assets | $11,052 | $10,961 | $11,030 | $10,991 | $10,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 150 | 190 | 182 | 173 | 0 |
| Accounts payable and accrued liabilities | 852 | 445 | 229 | 150 | 100 |
| Accrued Expenses | N/A | N/A | 256 | 304 | 370 |
| TOTAL | $1,009 | $636 | $666 | $635 | $520 |
| Non-Current Liabilities | |||||
| Long Term Debt | 746 | 896 | 1,087 | 1,268 | 940 |
| Deferred Revenues | 7 | 0 | N/A | 8 | N/A |
| Other Non-Current Liabilities | 39 | 33 | 83 | 68 | 0 |
| TOTAL | $785 | $929 | $1,170 | $1,336 | $940 |
| Total Liabilities | $1,794 | $1,565 | $1,836 | $1,971 | $1,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,028 | 3,027 | 3,019 | N/A | N/A |
| Common Shares | 326 | 326 | 326 | 326 | 320 |
| Retained earnings | -575 | -407 | -525 | -614 | -200 |
| Other shareholders' equity | 465 | 466 | 420 | 397 | 380 |
| TOTAL | $9,258 | $9,396 | $9,195 | $9,020 | $9,280 |
| Total Liabilities And Equity | $11,052 | $10,961 | $11,030 | $10,991 | $10,740 |